Comparison of Two Therapeutic Strategies for Treating Type 2 Diabetic Patients Poorly Controlled With Basal Insulin Associated With Oral Antidiabetic Drugs : 6-Month Proof of Concept Study.

Trial Profile

Comparison of Two Therapeutic Strategies for Treating Type 2 Diabetic Patients Poorly Controlled With Basal Insulin Associated With Oral Antidiabetic Drugs : 6-Month Proof of Concept Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2011

At a glance

  • Drugs Glimepiride; Insulin glargine; Insulin glulisine; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 01 Nov 2011 Results published in the Diabetes, Obesity and Metabolism.
    • 03 Feb 2010 Patient numbers amended from 135 to 106 as reported by ClinicalTrials.gov.
    • 05 Jun 2009 Status changed from active, no longer recruiting to completed, according to results presented at the 69th Annual Scientific Sessions of the American Diabetes Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top